Nelson J C, Mazure C M, Jatlow P I
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510.
J Affect Disord. 1990 Mar;18(3):157-65. doi: 10.1016/0165-0327(90)90032-4.
We examined the value of the melancholic distinction for predicting response to 1 week of hospitalization without antidepressant drugs and to a 4-week fixed plasma level desipramine (DMI) trial in patients with unipolar non-psychotic major depression. Both DSM-III and III-R criteria were tested. Response to hospitalization (HDRS less than or equal to 12) was much less common in DSM-III melancholic than in non-melancholic patients (1 of 19 vs. 18 of 37, chi 2 = 8.69, df = 1, P less than 0.001) and severity did not account for this association. DSM-III-R melancholia criteria were also associated with poor hospital response but slightly less predictive. Melancholic patients, however, diagnosed with either set of criteria, were not more likely to respond to drug treatment on any of the measures examined.
我们研究了抑郁质区分对于预测单相非精神病性重度抑郁症患者在无抗抑郁药物情况下住院1周以及进行为期4周的固定血浆水平地昔帕明(DMI)试验的反应的价值。对DSM-III和III-R标准均进行了测试。在DSM-III抑郁质患者中,对住院治疗的反应(汉密尔顿抑郁量表评分小于或等于12)比非抑郁质患者少见得多(19例中的1例 vs. 37例中的18例,χ2 = 8.69,自由度 = 1,P < 0.001),且严重程度并不能解释这种关联。DSM-III-R抑郁质标准也与住院反应不佳相关,但预测性稍低。然而,无论根据哪一套标准诊断为抑郁质的患者,在所检查的任何指标上对药物治疗的反应都没有更高的可能性。